we announce the winners of our first volunteer awards
2019 was another exciting year of progress. Here are 8 of the highlights, and 8 ways you can still get involved.
Researchers, funded by Parkinson's UK, have produced positive results in mice for a gene therapy treatment that directly targets the production of the alpha-synuclein protein.
Survey we supported shares findings that people with advanced or terminal illness support a change in the law on assisted dying
Alongside Alzheimer’s Research UK, we’re funding new research that will investigate whether boosting the brain’s self-cleaning system could be the key to new treatments.
The report, Get It On Time, highlights systematic failures in Scotland’s hospitals that mean that people with Parkinson’s don’t receive their vital medication at their prescribed times.
The Parkinson’s community in Scotland, and beyond, has lost one of its giants with the passing of Professor Ken Bowler. Ken revolutionised the relationship between researchers and people living with Parkinson’s.
Former professional footballers are more likely to die with a neurodegenerative condition such as dementia or Parkinson's than the general population, according to new research.
A pioneering clinical trial will investigate if cannabidiol (CBD) – a compound found in the cannabis plant – can treat hallucinations and delusions in people living with Parkinson’s.
A phase II clinical trial of tavapadon, a drug developed by Cerevel Therapeutics, has shown improvements in movement symptoms. The results have been announced on the company website.
Researchers have shown that those taking part in a home-based exercise programme experienced improvements in their motor symptoms.
New data shows that some people waiting to get Personal Independence Payments has increased to over a year
A drug used to treat enlarged prostates may have exciting potential for slowing down Parkinson's, according to research published in the Journal of Clinical Investigation.
Mark Goodridge will retire as chair in October, and Gary Shaughnessy has been elected as his successor
Researchers have shown that boosting levels of oestrogen in the brains of mice improved symptoms by slowing the build-up of the toxic protein alpha-synuclein.
Researchers have shown that an ‘easy to use’ portable stimulation headset may be able to reduce both motor and non-motor symptoms of Parkinson’s.
A new report from the Disability Benefits Consortium shows how changes to the benefits system have had a devastating impact on disabled people.
Earlier this year, we surveyed 1,600 people with Parkinson's and 29 health professionals about using cannabis-derived products. Here are the results.